SINT vs. MODD, ECOR, MLSS, DRIO, POCI, RBOT, STRR, PETV, NRXS, and CLGN
Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Modular Medical (MODD), electroCore (ECOR), Milestone Scientific (MLSS), DarioHealth (DRIO), Precision Optics (POCI), Vicarious Surgical (RBOT), Star Equity (STRR), PetVivo (PETV), NeurAxis (NRXS), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry.
Sintx Technologies vs. Its Competitors
Sintx Technologies (NASDAQ:SINT) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
Sintx Technologies has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500.
Sintx Technologies has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Comparatively, 20.5% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Sintx Technologies had 1 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Sintx Technologies and 2 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.47 beat Sintx Technologies' score of 0.42 indicating that Modular Medical is being referred to more favorably in the news media.
Modular Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -674.05%. Modular Medical's return on equity of -185.60% beat Sintx Technologies' return on equity.
Sintx Technologies currently has a consensus target price of $25.00, indicating a potential upside of 474.71%. Given Sintx Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Sintx Technologies is more favorable than Modular Medical.
Summary
Sintx Technologies beats Modular Medical on 9 of the 15 factors compared between the two stocks.
Get Sintx Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sintx Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:SINT) was last updated on 10/10/2025 by MarketBeat.com Staff
